Mucinous carcinoma of the ovary

Oncology (Switzerland)

Volumn 53, Issue 4, 1996, Pages 303-307

  Kikkawa, Fumitaka ^a   Kawai, Michiyasu ^b   Tamakoshi, Koji ^a   Suganuma, Nobuhiko ^a   Nakashima, Nobuo ^a   Furuhashi, Yoshihito ^c   Kuzuya, Kazuo ^d   Hattori, Sen Ei ^e   Arii, Yoshitaro ^b   Tomoda, Yutaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c Okazaki City Hospital   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

^e OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

Endocervical type; Intestinal type; Mucinous cystadenocarcinoma; Ovarian carcinoma; Stromal invasion

Indexed keywords

ACLACINOMYCIN; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASCITES; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CELL VOLUME; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN CELL; INTESTINE CARCINOMA; MUCINOUS CARCINOMA; MULTIVARIATE ANALYSIS; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; STROMA CELL; SURVIVAL TIME; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA, MUCINOUS; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; CA-19-9 ANTIGEN; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 8944243554     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227577     Document Type: Article

References (10)

1. Nakashima N, Nagasaka T, Fukata S, et al: Study of ovarian tumors treated at Nagoya University Hospital, Gynecol Oncol 1990;37: 103-111.
2. Malkasian GD, Melton LJ, O'Brien PC, Greene MH: Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary, Am J Obstet Gynecol 1984:149:274-284.
3. Morikawa Y, Kawai M, Kano T, et al: Clinical remission criteria for epithelial carcinoma of the ovary, Gynecol Oncol 1993;48:342-348.
4. Serov SF, Scully RE, Sobin LH: Histologic typing of ovarian tumors: International Histological Classification of Tumors, No, 9. Geneva World Health Organization, 1973.
5. Hart WR, Norris H: Borderline and malignant mucinous tumors of the ovary, Histologic criteria and clinical behavior, Cancer 1973;31: 1031-1045.
6. Hart WR: Ovarian epithelial tumors of borderline malignancy (carcinoma of low malignant potential), Hum Pathol 1977;8:541-549.
7. Rutgers JL, Scully RE: Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy, A clinicopathologic analysis, Cancer 1986;61:340-348.
8. Watkin WW, Silva EG, Gershenson DM: Mucinous carcinoma of the ovary, Pathologic prognostic factors, Cancer 1992;69:208-212.
9. Chaitin BA, Gershenson DM, Evans HL: Mucinous tumors of the ovary, A clinicopathologic study of 70 cases, Cancer 1985;55:1958-1962.
10. Kawai M, Kikkawa F, Mizuno K, et al: Stage I epithelial ovarian cancer, Adjuvant chemotherapy and prognostic factors, J Exp Clin Cancer Res 1994;13:77-81.